Table 2 Concomitant medication and concomitant diseases
variable | 6% HES 130/0.42 (n = 30) | 4% gelatin (n = 30) | 6% HES 200/0.5 (n = 30) | p-value |
|---|---|---|---|---|
asperine | 15 | 17 | 19 | > 0.2 |
NSAR | 0 | 3 | 1 | 0.1129 |
clopidogrel | 1 | 5 | 5 | 0.1351 |
phenprocoumon | 2 | 1 | 3 | > 0.2 |
beta blocker | 19 | 19 | 19 | > 0.2 |
calcium channel blocker | 6 | 3 | 3 | > 0.2 |
ACE-inhibitors | 17 | 17 | 17 | > 0.2 |
diuretic | 14 | 16 | 13 | > 0.2 |
digoxin | 3 | 4 | 2 | > 0.2 |
statine drug | 14 | 17 | 17 | > 0.2 |
nitrate | 8 | 5 | 7 | > 0.2 |
arterial hypertension | 21 | 18 | 20 | > 0.2 |
pulmonary hypertension | 3 | 3 | 1 | > 0.2 |
diabetes mellitus | 4 | 8 | 8 | > 0.2 |
smoker | 4 | 10 | 10 | 0.1176 |
hypercholesteremia | 11 | 11 | 15 | > 0.2 |
adiposity | 7 | 12 | 10 | > 0.2 |
coronary artery disease | 20 | 21 | 26 | 0.1636 |
familial heart diseases | 1 | 3 | 6 | 0.1166 |
left main (coronary artery) stenosis | 6 | 9 | 11 | > 0.2 |
multi-vessel coronary disease | 16 | 20 | 19 | > 0.2 |
myocardial infarction | 2 | 7 | 8 | 0.1192 |
atrial fibrillation | 4 | 4 | 3 | > 0.2 |
ischemic cardiomyopathy | 2 | 2 | 0 | 0.1886 |
mitral valve insufficiency | 9 | 7 | 6 | > 0.2 |
aortic valve insufficiency | 8 | 4 | 4 | > 0.2 |
aortic valve stenosis | 10 | 4 | 10 | 0.1293 |
COPD | 7 | 10 | 4 | 0.1869 |